Hjem › Kolorektal kreft › Texas › Austin
Kliniske studier for Kolorektal kreft i Austin, TX
19 studier for Kolorektal kreft søker deltakere på steder i og rundt Austin (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- NEXT Austin, Austin
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruttererFase 1/2
- New Experimental Therapeutics - NEXT Oncology, Austin
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekruttererFase 1
- Exelixis Clinical Site #46, Austin
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
RekruttererFase 2
- Texas Oncology - Austin Midtown /ID# 271354, Austin
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
RekruttererFase 2/3
- Texas Oncology, PA, Austin
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
RekruttererFase 3
- Ascension Seton Spclty Care Ctr, Austin
- Texas Oncology, Austin
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
RekruttererFase 3
- Texas Oncology-South Austin, Austin
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
RekruttererFase 1
- NEXT Austin, Austin
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Texas Oncology - Central/South Texas, Austin
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RekruttererFase 1
- Texas Oncology - Central South, Austin
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
RekruttererFase 2
- Texas Oncology - Central/South Texas /ID# 275154, Austin
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RekruttererFase 1
- NEXT Texas LLC - Austin, Austin
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
RekruttererFase 1
- NEXT Texas LLC - Austin, Austin
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
RekruttererFase 2
- Texas Oncology - Central/South Texas, Austin
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekruttererFase 1/2
- University of Texas at Austin, Austin
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
RekruttererFase 1
- NEXT Oncology, Austin, TX 78758
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Elligo Health Research, Inc., Austin
Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Natera, Inc, Austin
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Natera, Austin
Kolorektal kreft-studier i andre byer
- Houston, TX102 studier
- New York City, NY78 studier
- Nashville, TN69 studier
- Boston, MA63 studier
- Los Angeles, CA59 studier
- Arlington, VA52 studier
- St. Louis, MO50 studier
- San Antonio, TX46 studier
- Philadelphia, PA44 studier
- Grand Rapids, MI40 studier
- Baldwin Park, CA37 studier
- Chicago, IL34 studier
Andre studier i Austin
- Ikke-småcellet lungekreft30 studier
- Kreft (alle typer)20 studier
- Fedme20 studier
- Metastatisk kreft19 studier
- Overvekt18 studier
- Hjertesvikt18 studier
- Brystkreft18 studier
- Eggstokkreft17 studier
- Endometriekreft15 studier
- Prostatakreft15 studier
- Depresjon14 studier
- Schizofreni13 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.